"Designing Growth Strategies is in our DNA"
The Germany hepatitis C testing market size was USD 106.8 million in 2019. The impact of COVID-19 has been unprecedented and staggering on Germany, with the hepatitis C testing witnessing a negative impact on demand across Germany. Based on our analysis, the market will exhibit a huge decline of -25.0% in 2020. It is projected to grow from USD 80.1 million in 2020 to USD 121.4 million in 2027 at a CAGR of 6.1% in the 2020-2027 period. The sudden rise in CAGR is attributable to this market’s demand and growth, returning to pre-pandemic levels once the pandemic is over.
Hepatitis C is one of the most commonly occurring infectious diseases in Germany. Several initiatives have been undertaken in the country to understand the disease trends, such as prevalence and the most common genotypes. It is a liver disease caused by the hepatitis C virus (HCV), and if left untreated, the disease can contribute to the development of liver cancer. While Germany has historically recorded a lower prevalence of hepatitis C compared to developing countries, the country has witnessed several changes in its demographics in recent times. The increasing influx of migrants and rising abuse of drugs through injections among the general population is expected to sharply increase the hepatitis C prevalence in the country. As these changing trends in the German populace are expected to lead to a greater need for HCV testing, the market is poised for significant growth in the forecast period.
Priority to COVID-19 Testing will Result in a Significant Decline in Hepatitis C Testing in Germany
The COVID-19 pandemic on the Germany hepatitis C testing has been significantly adverse due to a number of critical factors. Because of restrictions such as nationwide lockdowns enforced by the German government, the testing for hepatitis C was severely impacted. This is because the resources used in the testing were diverted to the efforts of the tackling of the coronavirus, and the HCV testing for non-critical patients was deemed unnecessary. Furthermore, a study published in December 2020 in the Journal of Primary Care and Community Health stated that the COVID-19 pandemic led to a 50% decline in hepatitis C testing. Hence, as of now, the 2019-20 coronavirus pandemic is expected to have a severely negative impact on the German market.
Request a Free sample to learn more about this report.
Strong Initiatives towards the Elimination of Hepatitis C in Germany is a Vital Trend
The most critical trend of Germany's hepatitis C testing is the substantial initiatives undertaken by the German government for the elimination of hepatitis C. For instance, according to a research paper published in the medical journal BMJ Open in August 2020, it was noted that under the current practice, the HCV diagnosis rates are expected to increase to 70% in Germany by 2030. Such positive trends in terms of the increase of HCV testing in the country are expected to significantly aid in the growth of the market in the forecast period.
Furthermore, the German government has a strategic plan in place for the elimination of hepatitis C in the country, with the latest plan being published in 2016. This is greatly expected to boost the demand for hepatitis C testing in Germany because of the increasing awareness amongst the German population towards this serious disease, coupled with positive initiatives by the government to boost the HCV testing volumes.
Increasing Prevalence of Hepatitis C in Germany to Surge Growth
An important driver of the German market is the increasing prevalence of hepatitis C amongst the population. The market is particularly poised for growth in the forecast period as the recent developments in the country’s demographic groups, such as the increasing influx of migrants are expected to increase the incidence of HCV infections. These changing demographics in Germany are expected to necessitate increased HCV testing as these migrants have been historically noted to show a greater prevalence of hepatitis C.
Furthermore, the increasing proportion of drug abusers who inject drugs in the general population is also expected to warrant the need for higher HCV testing volumes. While historically Germany has shown a lower prevalence of hepatitis C, these changing population trends are expected to result in a significant increase in the prevalence. Factors as such are projected to further boost the market growth during the forecast period.
Rising Awareness Programs to Boost the Market for Germany Hepatitis C Testing
One of the other critical driving factors of the market in Germany includes the increased awareness of the advantages of timely HCV infection diagnostics. This rising awareness amongst the general population is expected to significantly boost the testing rates in the country. For instance, a significant proportion of the population who suffer from HCV infection develop the chronic form of this disease. Individuals, who suffer from chronic hepatitis C, are more susceptible to developing other serious diseases such as liver cancer and liver failure.
As the awareness increases in the general population regarding the early treatment through acting antivirals, a significant proportion of the population is expected to opt for HCV testing. Hence, robust investments in creating a comprehensive hepatitis C testing initiative and the increasing involvement of major and emerging players in the creation of testing awareness are expected to boost the market growth in the forecast period.
Absence of Nationwide HCV Testing Program in Germany to Limit Growth
One of the most critical restraining factors impacting the widespread adoption of hepatitis C testing in Germany is the absence of a nationwide testing program. The absence of a comprehensive HCV testing initiative has led to the adoption of hepatitis C testing in the country despite an increase in the incidence of the disease. Numerous clinical publications point out that there is a strong requirement for a nationwide hepatitis C testing initiative in Germany. Furthermore, the lack of widespread HCV testing in the country is anticipated to not enable Germany to fulfill the World Health Organization’s (WHO) goal of HCV elimination by 2030. These factors are anticipated to limit the Germany hepatitis C testing market growth during the forecast period.
To know how our report can help streamline your business, Speak to Analyst
HCV Serologic Tests (HCV Ab) Segment to Grow at Faster Pace during 2020-2027
Based on test types, the market can be segmented into HCV serologic tests (HCV Ab), HCV RNA tests, and HCV genotype tests. The HCV serologic tests (HCV Ab) segment held a dominant proportion of Germany hepatitis C testing in 2019. The dominance of the segment is owing to the large volumes of this test type to screen the general and vulnerable population for HCV antibodies. HCV serologic tests (HCV Ab) are conducted to determine whether an individual has the presence of HCV antibodies in their body. It indicates the presence of an active or recovered HCV infection.
The HCV RNA test segment is expected to register the second-largest market share due to the increasing testing volumes of this test type in order to determine whether the nature of HCV infection is active. Furthermore, HCV RNA tests are conducted to also measure for the purposes of detecting viral load at baseline, monitoring tests during the course of treatment, and post-treatment assessment.
The HCV genotype tests segment is anticipated to register a lower market share in the forecast period. This is primarily due to the comparatively lower testing volumes of this test type in Germany hepatitis C testing.
ELISA Segment Dominated the Market in 2019
Based on the technology type, the market is segmented into ELISA and PCR. The ELISA segment primarily dominated the market in 2019 because of the large testing volumes attributed to HCV serologic tests or the HCV antibody test. The HCV antibody test is based on the enzyme-linked immunoassay (ELISA) technology. The PCR technology type is the second most dominant segment because of the extensive usage of this technology for two types of hepatitis C testing. These two types of testing include the HCV RNA tests (quantitative and qualitative assays) and the HCV genotype tests.
Hospitals to Be the Largest Segment during the Forecast Period
On the basis of the end-user segment of Germany hepatitis C testing, the market is segmented into hospitals, diagnostics labs, and others. The hospitals segment is projected to account for the highest share in the market during the forecast period. The dominance of this segment is attributable to the fact that the German healthcare system comprises a large number of hospitals and clinics that often prescribe and undertake to test for hepatitis C. The diagnostics labs segment is expected to grow at a comparatively lower CAGR during the forecast period. The others segment consists of all the other medical and healthcare institutions in Germany, such as rehabilitation centers, which also undertake testing for hepatitis C in the country.
Strong Hepatitis C Testing Portfolio of Abbott and Roche Diagnostics to Help Them Dominate Germany Market
The Germany hepatitis C testing market depicts a competitive scenario, which includes a semi-consolidated industry with the presence of a few established and emerging companies. In the present scenario of hepatitis C testing in Germany, Abbott and Roche Diagnostics (Roche Diagnostics GmbH) were leading the market in 2019, accounting for a strong revenue share. Abbott dominates the market due to its comprehensive hepatitis C testing portfolio, which comprises HCV serologic tests (HCV Ab) and also HCV RNA tests.
Also, some of the other established players of Germany hepatitis C testing include Bio-Rad Laboratories and Siemens Healthineers. In the forecast period, these companies will focus on the expansion of their market presence in the country. This is because it is expected that the German government will intensify the country’s HCV testing efforts to meet the World Health Organization’s (WHO) goal of HCV elimination. These developments in the market in terms of hepatitis C virus testing are expected to aid in the recording of a higher growth rate in the forecast period.
An Infographic Representation of Germany Hepatitis C Testing Market
To get information on various segments, share your queries with us
The Germany hepatitis C testing market research report provides a detailed analysis of the market. It focuses on key aspects such as the prevalence of hepatitis C in Germany, regulatory and reimbursement scenario, key industry developments, number of hepatitis C tests, technological advancements in testing, and impact of COVID-19 outbreak on the market. Besides this, the report offers insights into the future market trends and highlights key industry dynamics. In addition to the aforementioned factors, it encompasses several factors that have contributed to the growth of the Germany market over recent years.
Value (USD Million)
Test Types, Technology Type, and End User
By Test Types
By Technology Type
By End User
Fortune Business Insights says that the market size was USD 106.8 million in 2019 and is projected to reach USD 121.4 million by 2027.
In 2019, the Germany market value stood at USD 106.8 million.
Registering a CAGR of 6.1%, the market will exhibit steady growth in the forecast period (2020-2027).
The HCV serologic tests (HCV Ab) segment is expected to lead this market during the forecast period.
The increasing prevalence of hepatitis C in Germany, strong government initiatives, and robust healthcare expenditure are major factors driving the growth of the market.
Abbott and Roche Diagnostics (Roche Diagnostics GmbH) are the major players in this market.
The increasing demand for hepatitis C testing in Germany, rising cases of this disease, strong governmental initiatives to increase HCV testing volumes, and robust potential patient population are expected to drive the adoption of testing services.
“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”- One of the Leading Food Companies in Germany
“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”- Intuitive Surgical
“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”- Major Food Company in Japan
“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”- Ziering Medical
“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”- Major Manufacturer of Precision Machine Parts in India
“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”- Hewlett-Packard
“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”- Global Management Consulting Firm
“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”- UK-based Start-up in the Medical Devices Sector
“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”- One of the Largest Companies in the Defence Industry